Ganoderma Spores for Mood After Thyroid Cancer Surgery
Part of Cancer, Hormones & metabolism clinical trials.
This study tests whether Ganoderma spores (a natural mushroom extract) can improve mood and depression in women who've had thyroid cancer surgery. The spores may work by changing the bacteria in your gut, which scientists believe affects brain health and mood.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman aged 18–80 years old
- You've had surgery for papillary thyroid carcinoma (a type of thyroid cancer) confirmed by tissue biopsy
- You have mild-to-moderate depressive symptoms but no prior history of depression or other psychiatric conditions
- You are Han Chinese ethnicity
- You haven't had stomach/intestinal surgery or current gastrointestinal diseases
- You haven't taken antibiotics or gut-health supplements in the past 3 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how you feel after thyroid surgery for cancer. It tests whether adding Chinese medicine treatments can help with symptoms like pain or fatigue during recovery.
This study looks at how people feel after thyroid surgery for low-risk papillary thyroid cancer. It aims to understand regret and may help improve support for those who have had surgery.
This trial tests if a single dose of psilocybin, given with therapy, can help cancer survivors who struggle with anxiety or depression. You would travel to MD Anderson for treatment and follow-up, and must stop certain medications beforehand.
This trial tests if a probiotic supplement (GynMDD) can boost the effects of supportive therapy for people with mild to moderate depression. If you're not taking antidepressants and have no suicidal thoughts, this may be an option for you.
This trial tests whether taking a turkey tail mushroom supplement before breast cancer surgery can help the immune system fight the cancer. It is for post-menopausal women with a common type of breast cancer (ER-positive, HER2-negative) that is growing at a moderate or faster rate (Ki-67 score of 10% or more).
This trial tests whether a single dose of psilocybin, a psychedelic medication, can safely and effectively treat major depression in people with cancer. If you have cancer and have been feeling depressed for at least a month, you may qualify.
Hear when a new Depression trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.